基本信息
浏览量:2
职业迁徙
个人简介
Dr. Andreazza is a Professor in the Departments of Pharmacology & Toxicology and Psychiatry and holds a holding Tier II Canada Research Chair in Molecular Pharmacology of Mood Disorders and the Thomas C. Zachos Chair in Mitochondrial Research. Dr. Andreazza received PhD in Biochemistry from the Federal University of Rio Grande do Sul, RS, Brazil. She has published over 150 research articles with an h-index factor of 45. She is the recipient of several prestigious research awards, including the 2018 Canada Top 40 Under 40 and has received funding from the Brain and Behavior Foundation (NARSAD), the Canadian Institutes for Health Research, the Ontario Mental Health Foundation and the Ontario Ministry of Research and Innovation. Her research focuses on the understanding of the role of redox modulations and mitochondrial dysfunction in mental illness, especially in mood disorders.
Dr. Andreazza's research focuses on the understanding of the role of mitochondrial function in mental illness, especially in mood disorders. As neurons depend on mitochondrial function, dysfunctional mitochondrial during neurodevelopment is expected to impact neurotransmission with potentially crucial implications for mood disorders. Currently, Dr. Andreazza is evaluating the impact of mitochondrial dysfunction on neurotransmission using 3D brain organoids generated from induced pluripotent stem cells from patients with bipolar disorder and/or mitochondrial disease.
To accelerate the discovery of effective therapeutic approaches to treat mitochondrial dysfunction/disease, Dr. Andreazza founded the mitoNET.ca, which after successful fundraising and support from the University of Toronto became MITO2i. The objective is to unite researchers from different medical fields with a common interest in unveiling the role of mitochondrial function and genetics in human diseases and transform mitochondrial health.
Dr. Andreazza's research focuses on the understanding of the role of mitochondrial function in mental illness, especially in mood disorders. As neurons depend on mitochondrial function, dysfunctional mitochondrial during neurodevelopment is expected to impact neurotransmission with potentially crucial implications for mood disorders. Currently, Dr. Andreazza is evaluating the impact of mitochondrial dysfunction on neurotransmission using 3D brain organoids generated from induced pluripotent stem cells from patients with bipolar disorder and/or mitochondrial disease.
To accelerate the discovery of effective therapeutic approaches to treat mitochondrial dysfunction/disease, Dr. Andreazza founded the mitoNET.ca, which after successful fundraising and support from the University of Toronto became MITO2i. The objective is to unite researchers from different medical fields with a common interest in unveiling the role of mitochondrial function and genetics in human diseases and transform mitochondrial health.
研究兴趣
论文共 352 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Current neuropharmacologyno. 9 (2023): S161-S161
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRYno. 3 (2023): S116-S117
引用0浏览0引用
0
0
Current Neuropharmacology (2023)
引用0浏览0引用
0
0
Biological psychiatry global open scienceno. 2 (2023): 197-203
Biological Psychiatryno. 9 (2023): S168-S168
引用0浏览0引用
0
0
Mitochondrial Intoxicationpp.323-349, (2023)
Mitochondrion (2023): 1-10
Journal of affective disorders (2023): 149-159
European Neuropsychopharmacology (2023): S227-S228
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn